0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 5α-Reductase Inhibitors Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-8L18969
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global 5α Reductase Inhibitors Market Research Report 2025
BUY CHAPTERS

Global 5α-Reductase Inhibitors Market Research Report 2025

Code: QYRE-Auto-8L18969
Report
January 2025
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

5α-Reductase Inhibitors Market Size

The global market for 5α-Reductase Inhibitors was valued at US$ 862 million in the year 2024 and is projected to reach a revised size of US$ 1305 million by 2031, growing at a CAGR of 6.1% during the forecast period.

5α-Reductase Inhibitors Market

5α-Reductase Inhibitors Market

5α-Reductase inhibitors are a class of medications that block the action of the enzyme 5α-reductase, which converts testosterone into dihydrotestosterone (DHT), a more potent androgen. By reducing DHT levels, these inhibitors can help treat conditions such as benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness). Common examples include finasteride and dutasteride.
North American market for 5α-Reductase Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for 5α-Reductase Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of 5α-Reductase Inhibitors include Organon, GSK, Waylis Therapeutics, Dr. Reddy's Laboratories, Teva, Aurobindo Pharma, Zydus, Hetero, Accord Healthcare, Sun Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for 5α-Reductase Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 5α-Reductase Inhibitors.
The 5α-Reductase Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 5α-Reductase Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 5α-Reductase Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of 5α-Reductase Inhibitors Market Report

Report Metric Details
Report Name 5α-Reductase Inhibitors Market
Accounted market size in year US$ 862 million
Forecasted market size in 2031 US$ 1305 million
CAGR 6.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Dutasteride
  • Finasteride
Segment by Application
  • Male Pattern Baldness
  • Benign Prostatic Hyperplasia (BPH)
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Organon, GSK, Waylis Therapeutics, Dr. Reddy's Laboratories, Teva, Aurobindo Pharma, Zydus, Hetero, Accord Healthcare, Sun Pharma, Alkem, Amneal Pharmaceuticals, Strides Pharma, Chartwell, Humanwell Pharmaceutical, Grand Pharmaceutical, CR Double-Crane, Zhejiang Conba Pharmaceutical, Topfond Pharmaceutical, Zhejiang Xianju Pharmaceutical, Shanghai Shyndec Pharmaceutical, Humanwell Puracap, Sichuan Gowell Pharmaceutical, Chengdu Suncadia Medicine, Qilu Pharmaceutical, Jiangsu Wangao Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of 5α-Reductase Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of 5α-Reductase Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is 5α-Reductase Inhibitors Market growing?

Ans: The 5α-Reductase Inhibitors Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the 5α-Reductase Inhibitors Market size in 2031?

Ans: The 5α-Reductase Inhibitors Market size in 2031 will be US$ 1305 million.

Who are the main players in the 5α-Reductase Inhibitors Market report?

Ans: The main players in the 5α-Reductase Inhibitors Market are Organon, GSK, Waylis Therapeutics, Dr. Reddy's Laboratories, Teva, Aurobindo Pharma, Zydus, Hetero, Accord Healthcare, Sun Pharma, Alkem, Amneal Pharmaceuticals, Strides Pharma, Chartwell, Humanwell Pharmaceutical, Grand Pharmaceutical, CR Double-Crane, Zhejiang Conba Pharmaceutical, Topfond Pharmaceutical, Zhejiang Xianju Pharmaceutical, Shanghai Shyndec Pharmaceutical, Humanwell Puracap, Sichuan Gowell Pharmaceutical, Chengdu Suncadia Medicine, Qilu Pharmaceutical, Jiangsu Wangao Pharmaceutical

What are the Application segmentation covered in the 5α-Reductase Inhibitors Market report?

Ans: The Applications covered in the 5α-Reductase Inhibitors Market report are Male Pattern Baldness, Benign Prostatic Hyperplasia (BPH), Other

What are the Type segmentation covered in the 5α-Reductase Inhibitors Market report?

Ans: The Types covered in the 5α-Reductase Inhibitors Market report are Dutasteride, Finasteride

Recommended Reports

Prostate Health Drugs

Hair Loss Solutions

Hormonal & Androgen Blockade

1 5α-Reductase Inhibitors Market Overview
1.1 Product Definition
1.2 5α-Reductase Inhibitors by Type
1.2.1 Global 5α-Reductase Inhibitors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Dutasteride
1.2.3 Finasteride
1.3 5α-Reductase Inhibitors by Application
1.3.1 Global 5α-Reductase Inhibitors Market Value by Application (2024 VS 2031)
1.3.2 Male Pattern Baldness
1.3.3 Benign Prostatic Hyperplasia (BPH)
1.3.4 Other
1.4 Global 5α-Reductase Inhibitors Market Size Estimates and Forecasts
1.4.1 Global 5α-Reductase Inhibitors Revenue 2020-2031
1.4.2 Global 5α-Reductase Inhibitors Sales 2020-2031
1.4.3 Global 5α-Reductase Inhibitors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 5α-Reductase Inhibitors Market Competition by Manufacturers
2.1 Global 5α-Reductase Inhibitors Sales Market Share by Manufacturers (2020-2025)
2.2 Global 5α-Reductase Inhibitors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global 5α-Reductase Inhibitors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of 5α-Reductase Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 5α-Reductase Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 5α-Reductase Inhibitors, Product Type & Application
2.7 Global Key Manufacturers of 5α-Reductase Inhibitors, Date of Enter into This Industry
2.8 Global 5α-Reductase Inhibitors Market Competitive Situation and Trends
2.8.1 Global 5α-Reductase Inhibitors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest 5α-Reductase Inhibitors Players Market Share by Revenue
2.8.3 Global 5α-Reductase Inhibitors Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 5α-Reductase Inhibitors Market Scenario by Region
3.1 Global 5α-Reductase Inhibitors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global 5α-Reductase Inhibitors Sales by Region: 2020-2031
3.2.1 Global 5α-Reductase Inhibitors Sales by Region: 2020-2025
3.2.2 Global 5α-Reductase Inhibitors Sales by Region: 2026-2031
3.3 Global 5α-Reductase Inhibitors Revenue by Region: 2020-2031
3.3.1 Global 5α-Reductase Inhibitors Revenue by Region: 2020-2025
3.3.2 Global 5α-Reductase Inhibitors Revenue by Region: 2026-2031
3.4 North America 5α-Reductase Inhibitors Market Facts & Figures by Country
3.4.1 North America 5α-Reductase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America 5α-Reductase Inhibitors Sales by Country (2020-2031)
3.4.3 North America 5α-Reductase Inhibitors Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe 5α-Reductase Inhibitors Market Facts & Figures by Country
3.5.1 Europe 5α-Reductase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe 5α-Reductase Inhibitors Sales by Country (2020-2031)
3.5.3 Europe 5α-Reductase Inhibitors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 5α-Reductase Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific 5α-Reductase Inhibitors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific 5α-Reductase Inhibitors Sales by Region (2020-2031)
3.6.3 Asia Pacific 5α-Reductase Inhibitors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 5α-Reductase Inhibitors Market Facts & Figures by Country
3.7.1 Latin America 5α-Reductase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America 5α-Reductase Inhibitors Sales by Country (2020-2031)
3.7.3 Latin America 5α-Reductase Inhibitors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa 5α-Reductase Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa 5α-Reductase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa 5α-Reductase Inhibitors Sales by Country (2020-2031)
3.8.3 Middle East and Africa 5α-Reductase Inhibitors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 5α-Reductase Inhibitors Sales by Type (2020-2031)
4.1.1 Global 5α-Reductase Inhibitors Sales by Type (2020-2025)
4.1.2 Global 5α-Reductase Inhibitors Sales by Type (2026-2031)
4.1.3 Global 5α-Reductase Inhibitors Sales Market Share by Type (2020-2031)
4.2 Global 5α-Reductase Inhibitors Revenue by Type (2020-2031)
4.2.1 Global 5α-Reductase Inhibitors Revenue by Type (2020-2025)
4.2.2 Global 5α-Reductase Inhibitors Revenue by Type (2026-2031)
4.2.3 Global 5α-Reductase Inhibitors Revenue Market Share by Type (2020-2031)
4.3 Global 5α-Reductase Inhibitors Price by Type (2020-2031)
5 Segment by Application
5.1 Global 5α-Reductase Inhibitors Sales by Application (2020-2031)
5.1.1 Global 5α-Reductase Inhibitors Sales by Application (2020-2025)
5.1.2 Global 5α-Reductase Inhibitors Sales by Application (2026-2031)
5.1.3 Global 5α-Reductase Inhibitors Sales Market Share by Application (2020-2031)
5.2 Global 5α-Reductase Inhibitors Revenue by Application (2020-2031)
5.2.1 Global 5α-Reductase Inhibitors Revenue by Application (2020-2025)
5.2.2 Global 5α-Reductase Inhibitors Revenue by Application (2026-2031)
5.2.3 Global 5α-Reductase Inhibitors Revenue Market Share by Application (2020-2031)
5.3 Global 5α-Reductase Inhibitors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Organon
6.1.1 Organon Company Information
6.1.2 Organon Description and Business Overview
6.1.3 Organon 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Organon 5α-Reductase Inhibitors Product Portfolio
6.1.5 Organon Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK 5α-Reductase Inhibitors Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Waylis Therapeutics
6.3.1 Waylis Therapeutics Company Information
6.3.2 Waylis Therapeutics Description and Business Overview
6.3.3 Waylis Therapeutics 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Waylis Therapeutics 5α-Reductase Inhibitors Product Portfolio
6.3.5 Waylis Therapeutics Recent Developments/Updates
6.4 Dr. Reddy's Laboratories
6.4.1 Dr. Reddy's Laboratories Company Information
6.4.2 Dr. Reddy's Laboratories Description and Business Overview
6.4.3 Dr. Reddy's Laboratories 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dr. Reddy's Laboratories 5α-Reductase Inhibitors Product Portfolio
6.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva 5α-Reductase Inhibitors Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Aurobindo Pharma
6.6.1 Aurobindo Pharma Company Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Aurobindo Pharma 5α-Reductase Inhibitors Product Portfolio
6.6.5 Aurobindo Pharma Recent Developments/Updates
6.7 Zydus
6.7.1 Zydus Company Information
6.7.2 Zydus Description and Business Overview
6.7.3 Zydus 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zydus 5α-Reductase Inhibitors Product Portfolio
6.7.5 Zydus Recent Developments/Updates
6.8 Hetero
6.8.1 Hetero Company Information
6.8.2 Hetero Description and Business Overview
6.8.3 Hetero 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hetero 5α-Reductase Inhibitors Product Portfolio
6.8.5 Hetero Recent Developments/Updates
6.9 Accord Healthcare
6.9.1 Accord Healthcare Company Information
6.9.2 Accord Healthcare Description and Business Overview
6.9.3 Accord Healthcare 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Accord Healthcare 5α-Reductase Inhibitors Product Portfolio
6.9.5 Accord Healthcare Recent Developments/Updates
6.10 Sun Pharma
6.10.1 Sun Pharma Company Information
6.10.2 Sun Pharma Description and Business Overview
6.10.3 Sun Pharma 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sun Pharma 5α-Reductase Inhibitors Product Portfolio
6.10.5 Sun Pharma Recent Developments/Updates
6.11 Alkem
6.11.1 Alkem Company Information
6.11.2 Alkem Description and Business Overview
6.11.3 Alkem 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Alkem 5α-Reductase Inhibitors Product Portfolio
6.11.5 Alkem Recent Developments/Updates
6.12 Amneal Pharmaceuticals
6.12.1 Amneal Pharmaceuticals Company Information
6.12.2 Amneal Pharmaceuticals Description and Business Overview
6.12.3 Amneal Pharmaceuticals 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Amneal Pharmaceuticals 5α-Reductase Inhibitors Product Portfolio
6.12.5 Amneal Pharmaceuticals Recent Developments/Updates
6.13 Strides Pharma
6.13.1 Strides Pharma Company Information
6.13.2 Strides Pharma Description and Business Overview
6.13.3 Strides Pharma 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Strides Pharma 5α-Reductase Inhibitors Product Portfolio
6.13.5 Strides Pharma Recent Developments/Updates
6.14 Chartwell
6.14.1 Chartwell Company Information
6.14.2 Chartwell Description and Business Overview
6.14.3 Chartwell 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Chartwell 5α-Reductase Inhibitors Product Portfolio
6.14.5 Chartwell Recent Developments/Updates
6.15 Humanwell Pharmaceutical
6.15.1 Humanwell Pharmaceutical Company Information
6.15.2 Humanwell Pharmaceutical Description and Business Overview
6.15.3 Humanwell Pharmaceutical 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Humanwell Pharmaceutical 5α-Reductase Inhibitors Product Portfolio
6.15.5 Humanwell Pharmaceutical Recent Developments/Updates
6.16 Grand Pharmaceutical
6.16.1 Grand Pharmaceutical Company Information
6.16.2 Grand Pharmaceutical Description and Business Overview
6.16.3 Grand Pharmaceutical 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Grand Pharmaceutical 5α-Reductase Inhibitors Product Portfolio
6.16.5 Grand Pharmaceutical Recent Developments/Updates
6.17 CR Double-Crane
6.17.1 CR Double-Crane Company Information
6.17.2 CR Double-Crane Description and Business Overview
6.17.3 CR Double-Crane 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.17.4 CR Double-Crane 5α-Reductase Inhibitors Product Portfolio
6.17.5 CR Double-Crane Recent Developments/Updates
6.18 Zhejiang Conba Pharmaceutical
6.18.1 Zhejiang Conba Pharmaceutical Company Information
6.18.2 Zhejiang Conba Pharmaceutical Description and Business Overview
6.18.3 Zhejiang Conba Pharmaceutical 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Zhejiang Conba Pharmaceutical 5α-Reductase Inhibitors Product Portfolio
6.18.5 Zhejiang Conba Pharmaceutical Recent Developments/Updates
6.19 Topfond Pharmaceutical
6.19.1 Topfond Pharmaceutical Company Information
6.19.2 Topfond Pharmaceutical Description and Business Overview
6.19.3 Topfond Pharmaceutical 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Topfond Pharmaceutical 5α-Reductase Inhibitors Product Portfolio
6.19.5 Topfond Pharmaceutical Recent Developments/Updates
6.20 Zhejiang Xianju Pharmaceutical
6.20.1 Zhejiang Xianju Pharmaceutical Company Information
6.20.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.20.3 Zhejiang Xianju Pharmaceutical 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Zhejiang Xianju Pharmaceutical 5α-Reductase Inhibitors Product Portfolio
6.20.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.21 Shanghai Shyndec Pharmaceutical
6.21.1 Shanghai Shyndec Pharmaceutical Company Information
6.21.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.21.3 Shanghai Shyndec Pharmaceutical 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Shanghai Shyndec Pharmaceutical 5α-Reductase Inhibitors Product Portfolio
6.21.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.22 Humanwell Puracap
6.22.1 Humanwell Puracap Company Information
6.22.2 Humanwell Puracap Description and Business Overview
6.22.3 Humanwell Puracap 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Humanwell Puracap 5α-Reductase Inhibitors Product Portfolio
6.22.5 Humanwell Puracap Recent Developments/Updates
6.23 Sichuan Gowell Pharmaceutical
6.23.1 Sichuan Gowell Pharmaceutical Company Information
6.23.2 Sichuan Gowell Pharmaceutical Description and Business Overview
6.23.3 Sichuan Gowell Pharmaceutical 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Sichuan Gowell Pharmaceutical 5α-Reductase Inhibitors Product Portfolio
6.23.5 Sichuan Gowell Pharmaceutical Recent Developments/Updates
6.24 Chengdu Suncadia Medicine
6.24.1 Chengdu Suncadia Medicine Company Information
6.24.2 Chengdu Suncadia Medicine Description and Business Overview
6.24.3 Chengdu Suncadia Medicine 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Chengdu Suncadia Medicine 5α-Reductase Inhibitors Product Portfolio
6.24.5 Chengdu Suncadia Medicine Recent Developments/Updates
6.25 Qilu Pharmaceutical
6.25.1 Qilu Pharmaceutical Company Information
6.25.2 Qilu Pharmaceutical Description and Business Overview
6.25.3 Qilu Pharmaceutical 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Qilu Pharmaceutical 5α-Reductase Inhibitors Product Portfolio
6.25.5 Qilu Pharmaceutical Recent Developments/Updates
6.26 Jiangsu Wangao Pharmaceutical
6.26.1 Jiangsu Wangao Pharmaceutical Company Information
6.26.2 Jiangsu Wangao Pharmaceutical Description and Business Overview
6.26.3 Jiangsu Wangao Pharmaceutical 5α-Reductase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Jiangsu Wangao Pharmaceutical 5α-Reductase Inhibitors Product Portfolio
6.26.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 5α-Reductase Inhibitors Industry Chain Analysis
7.2 5α-Reductase Inhibitors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 5α-Reductase Inhibitors Production Mode & Process Analysis
7.4 5α-Reductase Inhibitors Sales and Marketing
7.4.1 5α-Reductase Inhibitors Sales Channels
7.4.2 5α-Reductase Inhibitors Distributors
7.5 5α-Reductase Inhibitors Customer Analysis
8 5α-Reductase Inhibitors Market Dynamics
8.1 5α-Reductase Inhibitors Industry Trends
8.2 5α-Reductase Inhibitors Market Drivers
8.3 5α-Reductase Inhibitors Market Challenges
8.4 5α-Reductase Inhibitors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global 5α-Reductase Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global 5α-Reductase Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global 5α-Reductase Inhibitors Market Competitive Situation by Manufacturers in 2024
 Table 4. Global 5α-Reductase Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global 5α-Reductase Inhibitors Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global 5α-Reductase Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global 5α-Reductase Inhibitors Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market 5α-Reductase Inhibitors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of 5α-Reductase Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of 5α-Reductase Inhibitors, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of 5α-Reductase Inhibitors, Product Type & Application
 Table 12. Global Key Manufacturers of 5α-Reductase Inhibitors, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global 5α-Reductase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 5α-Reductase Inhibitors as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global 5α-Reductase Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global 5α-Reductase Inhibitors Sales by Region (2020-2025) & (K Units)
 Table 18. Global 5α-Reductase Inhibitors Sales Market Share by Region (2020-2025)
 Table 19. Global 5α-Reductase Inhibitors Sales by Region (2026-2031) & (K Units)
 Table 20. Global 5α-Reductase Inhibitors Sales Market Share by Region (2026-2031)
 Table 21. Global 5α-Reductase Inhibitors Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global 5α-Reductase Inhibitors Revenue Market Share by Region (2020-2025)
 Table 23. Global 5α-Reductase Inhibitors Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global 5α-Reductase Inhibitors Revenue Market Share by Region (2026-2031)
 Table 25. North America 5α-Reductase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America 5α-Reductase Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 27. North America 5α-Reductase Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 28. North America 5α-Reductase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America 5α-Reductase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe 5α-Reductase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe 5α-Reductase Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 32. Europe 5α-Reductase Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 33. Europe 5α-Reductase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe 5α-Reductase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific 5α-Reductase Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific 5α-Reductase Inhibitors Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific 5α-Reductase Inhibitors Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific 5α-Reductase Inhibitors Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific 5α-Reductase Inhibitors Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America 5α-Reductase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America 5α-Reductase Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America 5α-Reductase Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America 5α-Reductase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America 5α-Reductase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa 5α-Reductase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa 5α-Reductase Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa 5α-Reductase Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa 5α-Reductase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa 5α-Reductase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global 5α-Reductase Inhibitors Sales (K Units) by Type (2020-2025)
 Table 51. Global 5α-Reductase Inhibitors Sales (K Units) by Type (2026-2031)
 Table 52. Global 5α-Reductase Inhibitors Sales Market Share by Type (2020-2025)
 Table 53. Global 5α-Reductase Inhibitors Sales Market Share by Type (2026-2031)
 Table 54. Global 5α-Reductase Inhibitors Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global 5α-Reductase Inhibitors Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global 5α-Reductase Inhibitors Revenue Market Share by Type (2020-2025)
 Table 57. Global 5α-Reductase Inhibitors Revenue Market Share by Type (2026-2031)
 Table 58. Global 5α-Reductase Inhibitors Price (US$/Unit) by Type (2020-2025)
 Table 59. Global 5α-Reductase Inhibitors Price (US$/Unit) by Type (2026-2031)
 Table 60. Global 5α-Reductase Inhibitors Sales (K Units) by Application (2020-2025)
 Table 61. Global 5α-Reductase Inhibitors Sales (K Units) by Application (2026-2031)
 Table 62. Global 5α-Reductase Inhibitors Sales Market Share by Application (2020-2025)
 Table 63. Global 5α-Reductase Inhibitors Sales Market Share by Application (2026-2031)
 Table 64. Global 5α-Reductase Inhibitors Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global 5α-Reductase Inhibitors Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global 5α-Reductase Inhibitors Revenue Market Share by Application (2020-2025)
 Table 67. Global 5α-Reductase Inhibitors Revenue Market Share by Application (2026-2031)
 Table 68. Global 5α-Reductase Inhibitors Price (US$/Unit) by Application (2020-2025)
 Table 69. Global 5α-Reductase Inhibitors Price (US$/Unit) by Application (2026-2031)
 Table 70. Organon Company Information
 Table 71. Organon Description and Business Overview
 Table 72. Organon 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Organon 5α-Reductase Inhibitors Product
 Table 74. Organon Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK 5α-Reductase Inhibitors Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Waylis Therapeutics Company Information
 Table 81. Waylis Therapeutics Description and Business Overview
 Table 82. Waylis Therapeutics 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Waylis Therapeutics 5α-Reductase Inhibitors Product
 Table 84. Waylis Therapeutics Recent Developments/Updates
 Table 85. Dr. Reddy's Laboratories Company Information
 Table 86. Dr. Reddy's Laboratories Description and Business Overview
 Table 87. Dr. Reddy's Laboratories 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Dr. Reddy's Laboratories 5α-Reductase Inhibitors Product
 Table 89. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 90. Teva Company Information
 Table 91. Teva Description and Business Overview
 Table 92. Teva 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva 5α-Reductase Inhibitors Product
 Table 94. Teva Recent Developments/Updates
 Table 95. Aurobindo Pharma Company Information
 Table 96. Aurobindo Pharma Description and Business Overview
 Table 97. Aurobindo Pharma 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Aurobindo Pharma 5α-Reductase Inhibitors Product
 Table 99. Aurobindo Pharma Recent Developments/Updates
 Table 100. Zydus Company Information
 Table 101. Zydus Description and Business Overview
 Table 102. Zydus 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Zydus 5α-Reductase Inhibitors Product
 Table 104. Zydus Recent Developments/Updates
 Table 105. Hetero Company Information
 Table 106. Hetero Description and Business Overview
 Table 107. Hetero 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hetero 5α-Reductase Inhibitors Product
 Table 109. Hetero Recent Developments/Updates
 Table 110. Accord Healthcare Company Information
 Table 111. Accord Healthcare Description and Business Overview
 Table 112. Accord Healthcare 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Accord Healthcare 5α-Reductase Inhibitors Product
 Table 114. Accord Healthcare Recent Developments/Updates
 Table 115. Sun Pharma Company Information
 Table 116. Sun Pharma Description and Business Overview
 Table 117. Sun Pharma 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sun Pharma 5α-Reductase Inhibitors Product
 Table 119. Sun Pharma Recent Developments/Updates
 Table 120. Alkem Company Information
 Table 121. Alkem Description and Business Overview
 Table 122. Alkem 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Alkem 5α-Reductase Inhibitors Product
 Table 124. Alkem Recent Developments/Updates
 Table 125. Amneal Pharmaceuticals Company Information
 Table 126. Amneal Pharmaceuticals Description and Business Overview
 Table 127. Amneal Pharmaceuticals 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Amneal Pharmaceuticals 5α-Reductase Inhibitors Product
 Table 129. Amneal Pharmaceuticals Recent Developments/Updates
 Table 130. Strides Pharma Company Information
 Table 131. Strides Pharma Description and Business Overview
 Table 132. Strides Pharma 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Strides Pharma 5α-Reductase Inhibitors Product
 Table 134. Strides Pharma Recent Developments/Updates
 Table 135. Chartwell Company Information
 Table 136. Chartwell Description and Business Overview
 Table 137. Chartwell 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Chartwell 5α-Reductase Inhibitors Product
 Table 139. Chartwell Recent Developments/Updates
 Table 140. Humanwell Pharmaceutical Company Information
 Table 141. Humanwell Pharmaceutical Description and Business Overview
 Table 142. Humanwell Pharmaceutical 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Humanwell Pharmaceutical 5α-Reductase Inhibitors Product
 Table 144. Humanwell Pharmaceutical Recent Developments/Updates
 Table 145. Grand Pharmaceutical Company Information
 Table 146. Grand Pharmaceutical Description and Business Overview
 Table 147. Grand Pharmaceutical 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Grand Pharmaceutical 5α-Reductase Inhibitors Product
 Table 149. Grand Pharmaceutical Recent Developments/Updates
 Table 150. CR Double-Crane Company Information
 Table 151. CR Double-Crane Description and Business Overview
 Table 152. CR Double-Crane 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. CR Double-Crane 5α-Reductase Inhibitors Product
 Table 154. CR Double-Crane Recent Developments/Updates
 Table 155. Zhejiang Conba Pharmaceutical Company Information
 Table 156. Zhejiang Conba Pharmaceutical Description and Business Overview
 Table 157. Zhejiang Conba Pharmaceutical 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Zhejiang Conba Pharmaceutical 5α-Reductase Inhibitors Product
 Table 159. Zhejiang Conba Pharmaceutical Recent Developments/Updates
 Table 160. Topfond Pharmaceutical Company Information
 Table 161. Topfond Pharmaceutical Description and Business Overview
 Table 162. Topfond Pharmaceutical 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Topfond Pharmaceutical 5α-Reductase Inhibitors Product
 Table 164. Topfond Pharmaceutical Recent Developments/Updates
 Table 165. Zhejiang Xianju Pharmaceutical Company Information
 Table 166. Zhejiang Xianju Pharmaceutical Description and Business Overview
 Table 167. Zhejiang Xianju Pharmaceutical 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Zhejiang Xianju Pharmaceutical 5α-Reductase Inhibitors Product
 Table 169. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
 Table 170. Shanghai Shyndec Pharmaceutical Company Information
 Table 171. Shanghai Shyndec Pharmaceutical Description and Business Overview
 Table 172. Shanghai Shyndec Pharmaceutical 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Shanghai Shyndec Pharmaceutical 5α-Reductase Inhibitors Product
 Table 174. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
 Table 175. Humanwell Puracap Company Information
 Table 176. Humanwell Puracap Description and Business Overview
 Table 177. Humanwell Puracap 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Humanwell Puracap 5α-Reductase Inhibitors Product
 Table 179. Humanwell Puracap Recent Developments/Updates
 Table 180. Sichuan Gowell Pharmaceutical Company Information
 Table 181. Sichuan Gowell Pharmaceutical Description and Business Overview
 Table 182. Sichuan Gowell Pharmaceutical 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Sichuan Gowell Pharmaceutical 5α-Reductase Inhibitors Product
 Table 184. Sichuan Gowell Pharmaceutical Recent Developments/Updates
 Table 185. Chengdu Suncadia Medicine Company Information
 Table 186. Chengdu Suncadia Medicine Description and Business Overview
 Table 187. Chengdu Suncadia Medicine 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Chengdu Suncadia Medicine 5α-Reductase Inhibitors Product
 Table 189. Chengdu Suncadia Medicine Recent Developments/Updates
 Table 190. Qilu Pharmaceutical Company Information
 Table 191. Qilu Pharmaceutical Description and Business Overview
 Table 192. Qilu Pharmaceutical 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 193. Qilu Pharmaceutical 5α-Reductase Inhibitors Product
 Table 194. Qilu Pharmaceutical Recent Developments/Updates
 Table 195. Jiangsu Wangao Pharmaceutical Company Information
 Table 196. Jiangsu Wangao Pharmaceutical Description and Business Overview
 Table 197. Jiangsu Wangao Pharmaceutical 5α-Reductase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 198. Jiangsu Wangao Pharmaceutical 5α-Reductase Inhibitors Product
 Table 199. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
 Table 200. Key Raw Materials Lists
 Table 201. Raw Materials Key Suppliers Lists
 Table 202. 5α-Reductase Inhibitors Distributors List
 Table 203. 5α-Reductase Inhibitors Customers List
 Table 204. 5α-Reductase Inhibitors Market Trends
 Table 205. 5α-Reductase Inhibitors Market Drivers
 Table 206. 5α-Reductase Inhibitors Market Challenges
 Table 207. 5α-Reductase Inhibitors Market Restraints
 Table 208. Research Programs/Design for This Report
 Table 209. Key Data Information from Secondary Sources
 Table 210. Key Data Information from Primary Sources
 Table 211. Authors List of This Report


List of Figures
 Figure 1. Product Picture of 5α-Reductase Inhibitors
 Figure 2. Global 5α-Reductase Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global 5α-Reductase Inhibitors Market Share by Type: 2024 & 2031
 Figure 4. Dutasteride Product Picture
 Figure 5. Finasteride Product Picture
 Figure 6. Global 5α-Reductase Inhibitors Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global 5α-Reductase Inhibitors Market Share by Application: 2024 & 2031
 Figure 8. Male Pattern Baldness
 Figure 9. Benign Prostatic Hyperplasia (BPH)
 Figure 10. Other
 Figure 11. Global 5α-Reductase Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global 5α-Reductase Inhibitors Market Size (2020-2031) & (US$ Million)
 Figure 13. Global 5α-Reductase Inhibitors Sales (2020-2031) & (K Units)
 Figure 14. Global 5α-Reductase Inhibitors Average Price (US$/Unit) & (2020-2031)
 Figure 15. 5α-Reductase Inhibitors Report Years Considered
 Figure 16. 5α-Reductase Inhibitors Sales Share by Manufacturers in 2024
 Figure 17. Global 5α-Reductase Inhibitors Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest 5α-Reductase Inhibitors Players: Market Share by Revenue in 5α-Reductase Inhibitors in 2024
 Figure 19. 5α-Reductase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global 5α-Reductase Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America 5α-Reductase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 22. North America 5α-Reductase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 23. United States 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe 5α-Reductase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 26. Europe 5α-Reductase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 27. Germany 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific 5α-Reductase Inhibitors Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific 5α-Reductase Inhibitors Revenue Market Share by Region (2020-2031)
 Figure 34. China 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America 5α-Reductase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 42. Latin America 5α-Reductase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa 5α-Reductase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa 5α-Reductase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE 5α-Reductase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of 5α-Reductase Inhibitors by Type (2020-2031)
 Figure 53. Global Revenue Market Share of 5α-Reductase Inhibitors by Type (2020-2031)
 Figure 54. Global 5α-Reductase Inhibitors Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of 5α-Reductase Inhibitors by Application (2020-2031)
 Figure 56. Global Revenue Market Share of 5α-Reductase Inhibitors by Application (2020-2031)
 Figure 57. Global 5α-Reductase Inhibitors Price (US$/Unit) by Application (2020-2031)
 Figure 58. 5α-Reductase Inhibitors Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture